Guillain-Barre Syndrome Market Forecast Shows Rising Demand for Immunotherapy Treatments
Guillain-Barré Syndrome: Advancing Treatment with IVIG Therapy and Growing Market Opportunities Guillain-Barré syndrome (GBS) is a rare but serious autoimmune neurological disorder in which the body’s immune system mistakenly attacks the peripheral nerves. This condition can lead to rapid muscle weakness, tingling sensations, and in severe cases, paralysis or...
0 Comments 0 Shares 14 Views 0 Reviews